CELL-BASED IMMUNOTHERAPY FOR TREATMENT OF TRIPLE NEGATIVE BREAST CANCER STAGES II AND III

Status

Withdrawn

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506019-16-01

Acronym

aHyC-TNBC

Enrollment

Registered

2024-07-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TRIPLE NEGATIVE BREAST CANCER

None listed

Sex/Gender

All

Age

18 Years to No maximum

Slovenia

None listed

Source: EU CTIS · Data processed: Feb 4, 2026